Biosensors Market expected to be worth $31.5 billion by 2024

(IT-NEWSWIRE.COM, June 05, 2019 ) The Report "Biosensors Market by Type (Sensor patch and embedded device), Product (Wearable and nonwearable), Technology (Electrochemical and optical), Application (POC, Home Diagnostics, Research Lab, Food & Beverages), and Geography - Global Forecast to 2024", is expected to grow from USD 21.2 billion in 2019 to USD 31.5 billion by 2024, at a CAGR of 8.3%. Factors such as continuous technological advancements in biosensors ecosystem, increase in the use of biosensors for nonmedical applications, lucrative growth in POC diagnostics, and rise in demand for glucose monitoring systems are driving the growth of the biosensors market.

Don’t miss out on business opportunities in Biosensors Market. Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=798

Embedded device held larger size of biosensor market during forecast period

The growth of embedded devices is attributed to its implementation in environment monitoring, biodefence, and food & beverages to detect and remove contaminants, whether nonliving or living entities. These biosensors can be used for the detection of a broad spectrum of biological analytes and have shown greater responses and success in medical laboratories, food bioanalysis, and microbial detection. Detection of lower or higher limits of glucose in body, microbial invasion in body and food, heavy metals detection in soil and water, air-borne microbes and pesticides in water and soil, and various harmful chemicals produced by body can be easily and timely monitored with precision using the different types of embedded biosensors.

Wearable segment to grow at higher CAGR during forecast period

Wearable biosensors can be considered as among the major developments in healthcare technology. Wearable devices monitoring health consist of different types of miniature biosensors capable of measuring physiological parameters, such as vital signs (heart rate, respiration rate, body and skin temperature, and oxygen saturation), skin conductance, blood pressure, electrocardiogram (ECG), electroencephalography (EEG), acceleration, and rotation.

Browse and in-depth TOC on "Biosensors Market"

73 - Tables

47 - Figures

193 - Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/biosensors-market-798.html

North America held largest size of biosensors market in 2019

North America held the largest size of the biosensor market in 2019. PoC diagnostics is the fastest-growing application for biosensors in North America. The growth is attributed to the increase in addressable patient population. According to the American Medical Association and American Medical Group Association, more than 50% of Americans were living with one or more chronic diseases until 2012. The number of Americans suffering from chronic diseases was about 125 billion in 2000, which is expected to reach ~157 billion by 2022. The baby boomer population is witnessing a growth in incidences of chronic and infectious diseases. According to the US Census Bureau, the number of individuals over the age of 65 was 39.6 billion in 2009, which is expected to reach 72.1 billion by 2030.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=798

Key players operating in the biosensor market include Abbott Point of Care Inc. (US), Medtronic Inc. (US), LifeScan Inc. (US), Universal Biosensors Inc. (Australia), F. Hoffman-La Roche Ltd. (Switzerland), DuPont (US), Sysmex Corporation (Japan), Bio-Rad laboratories Inc. (US), Pharmaco-Kinesis Corporation (PKC) (US), Nova Biomedical Corp. (US), ACON Laboratories, Inc. (US), LifeSensors Inc. (US), Biacore (Sweden), and Biosensors International Pte. Ltd. (US).

Browse Adjacent Markets @ Semiconductor and Electronics Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

sales@marketsandmarkets.com

Visit MarketsandMarkets Blog@ http://www.marketsandmarketsblog.com/market-reports/electronics-and-semiconductors

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Website: http://www.marketsandmarkets.com/

MarketsandMarkets™

Mr. Shelly Singh

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com

Technology News & Search Engine

Biosensors Market expected to be worth $31.5 billion by 2024